Unknown

Dataset Information

Gene-Editing and RNA Interference in Treating Hepatitis B: A Review.


ABSTRACT: The hepatitis B virus (HBV) continues to cause substantial health and economic burdens, and its target of elimination may not be reached in 2030 without further efforts in diagnostics, non-pharmaceutical prevention measures, vaccination, and treatment. Current therapeutic options in chronic HBV, based on interferons and/or nucleos(t)ide analogs, suppress the virus replication but do not eliminate the pathogen and suffer from several constraints. This paper reviews the progress on biotechnological approaches in functional and definitive HBV treatments, including gene-editing tools, i.e., zinc-finger proteins, transcription activator-like effector nucleases, and CRISPR/Cas9, as well as therapeutics based on RNA interference. The advantages and challenges of these approaches are also discusse

SUBMITTER: Kasianchuk N 

PROVIDER: S-EPMC10747710 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature